News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
258 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18717)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (183)
2 (133)
5 (258)
6 (198)
7 (182)
8 (148)
9 (107)
12 (179)
13 (165)
14 (166)
15 (167)
16 (111)
19 (154)
20 (181)
21 (149)
22 (151)
23 (144)
26 (176)
27 (154)
28 (138)
29 (167)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Drug Development
With More than One-Year Follow-Up, Merck & Co.’s KEYTRUDA (Pembrolizumab) Shows Continued Overall Survival Benefit Over Chemotherapy As Second-Line Treatment For Advanced Urothelial Carcinoma Patients Post-Platinum Failure
June 5, 2017
·
4 min read
Drug Development
Bristol-Myers Squibb New Data Evaluating The Safety And Preliminary Relapse-Free Survival Of Adjuvant Yervoy (Ipilimumab) 3 Mg/Kg And 10 Mg/Kg In Resected High-Risk Melanoma Patients Presented At ASCO
June 5, 2017
·
2 min read
Drug Development
Bristol-Myers Squibb Release: First Presentation Of Efficacy Data From Checkmate -204 Evaluating The Combination Of Opdivo (Nivolumab) And Yervoy (Ipilimumab)Demonstrates Anti-Tumor Activity In Advanced Melanoma Patients With Brain Metastases
June 5, 2017
·
11 min read
Drug Development
AstraZeneca PLC Release: LYNPARZA (Olaparib) Significantly Reduces The Risk Of Disease Worsening Or Death In Patients With BRCA-Mutated Metastatic Breast Cancer
June 5, 2017
·
12 min read
Deals
Innate Pharma Regroups From Trial Failure With €410 Million Deal For Novo Nordisk A/S’s AntiC5aR Antibody
June 5, 2017
·
9 min read
Biotech Bay
EarLens Announces Final Close Of $118 Million Debt And Equity Financing
June 5, 2017
·
3 min read
Drug Development
NewLink Genetics Release: Results From Clinical Trial Of Indoximod Plus Chemotherapy For Patients With Metastatic Breast Cancer
June 5, 2017
·
3 min read
Pharm Country
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2017
·
2 min read
BioMidwest
Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering
June 5, 2017
·
3 min read
BioMidwest
Myriad Genetics Announces 17 Additional Health Insurance Plans Covering EndoPredict
June 5, 2017
·
6 min read
Previous
8 of 26
Next
